Prolotherapy for Pain Management
Prolotherapy (short for “proliferative therapy”) is an injection-based treatment used to manage chronic musculoskeletal pain. It involves injecting an irritant solution (commonly hypertonic dextrose) into ligaments, tendons, or joint spaces to promote tissue repair and reduce pain. Prolotherapy is primarily used for conditions like osteoarthritis, tendinopathies, low back pain, and ligament injuries.
Prolotherapy aims to stimulate the body’s natural healing processes through the following mechanisms:
- Tissue Repair and Regeneration:
- Strengthening Connective Tissue:
- By promoting collagen synthesis, prolotherapy helps restore the integrity of ligaments and tendons, improving joint stability and reducing pain (Rabago et al., 2011).
- Pain Modulation:
Does Prolotherapy actually work?
For many with chronic musculoskeletal pain and joint issues, prolotherapy can be effective in reducing pain and improving function by stimulating the body’s natural healing processes.
Evidence Supporting the success rate of Prolotherapy
Low Back Pain
Osteoarthritis
- Knee Osteoarthritis:
- A randomized controlled trial by Rabago et al. (2013) demonstrated that prolotherapy led to sustained pain reduction and functional improvement in patients with knee osteoarthritis over 52 weeks.
- Hip Osteoarthritis:
- Studies have reported similar benefits for hip osteoarthritis, with improved pain scores and range of motion after treatment (Topol et al., 2005).
Tendinopathies and Ligament Injuries
- Lateral Epicondylitis (Tennis Elbow):
- Plantar Fasciitis:
- Observational studies suggest prolotherapy is effective in reducing heel pain and improving functionality in plantar fasciitis patients (Kim et al., 2015).
Other Applications
- Temporomandibular Joint (TMJ) Pain:
- Evidence indicates that prolotherapy can alleviate TMJ-related pain and improve jaw function (Al-Moraissi et al., 2020).
- Sports Injuries:
- Athletes with ligament or tendon injuries have reported pain relief and faster return to activity following prolotherapy (Hauser et al., 2016).
Strengths of Prolotherapy
- Minimally Invasive:
- Prolotherapy offers a non-surgical option for managing chronic pain, appealing to patients seeking alternatives to invasive procedures.
- Long-Term Benefits:
- Unlike short-term pain relief strategies (e.g., corticosteroid injections), prolotherapy aims to address the underlying structural issues, providing lasting relief (Rabago et al., 2013).
Limitations and Considerations
- Evidence Quality:
- While many studies report positive outcomes, some lack robust methodology, including small sample sizes and limited long-term follow-up.
- Variable Response:
- Patient outcomes can vary, influenced by factors like the severity of the condition, injection technique, and adherence to rehabilitation protocols (Hauser et al., 2016).
- Pain and Inflammation:
- The treatment can cause temporary pain and swelling due to the inflammatory response, which may be uncomfortable for some patients (Kim et al., 2015).
Experience the Excel Pain and Wellness difference in Melbourne. Our expert team specializes in PRP treatments for different conditions. Contact us today for a personalised consultation. Make an appointment now!
References
- Al-Moraissi, E. A., Wolford, L. M., Perez, D., et al. (2020). The effectiveness of intra-articular injection of dextrose prolotherapy for temporomandibular joint hypermobility and chronic recurrent dislocation: A systematic review and meta-analysis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 130(2), 201–207.
- Hauser, R. A., Hauser, M. A., & Baird, N. (2016). Evidence-based use of dextrose prolotherapy for musculoskeletal pain: A practical guide for clinicians. Practical Pain Management, 16(4), 20–25.
- Kim, S. J., Choi, Y. C., & Lee, J. (2015). Efficacy of prolotherapy for the treatment of chronic plantar fasciitis: A meta-analysis of randomized controlled trials. Journal of Foot and Ankle Surgery, 54(5), 701–708.
- Rabago, D., Best, T. M., Beamsley, M., & Patterson, J. J. (2005). A systematic review of prolotherapy for chronic musculoskeletal pain. Clinical Journal of Sports Medicine, 15(5), 376–380.
- Rabago, D., Slattengren, A., & Zgierska, A. (2010). Prolotherapy in primary care practice. Primary Care: Clinics in Office Practice, 37(1), 65–80.
- Rabago, D., Zgierska, A., Fortney, L., et al. (2013). Hypertonic dextrose injections (prolotherapy) for knee osteoarthritis: Results of a single-arm uncontrolled study with 1-year follow-up. Journal of Alternative and Complementary Medicine, 19(7), 642–649.
- Reeves, K. D., & Hassanein, K. (2003). Randomized, prospective, placebo-controlled double-blind study of dextrose prolotherapy for osteoarthritic thumb and finger (DIP, PIP, and trapeziometacarpal) joints: Evidence of clinical efficacy. Journal of Alternative and Complementary Medicine, 9(3), 311–320.
- Scarpone, M., Rabago, D., Zgierska, A., et al. (2008). The efficacy of prolotherapy for lateral epicondylosis: A pilot study. Clinical Journal of Sport Medicine, 18(3), 248–254.
- Sit, R. W., Wu, R. W., Rabago, D., et al. (2020). Efficacy of dextrose prolotherapy for knee osteoarthritis: A meta-analysis and systematic review. Scientific Reports, 10(1), 18107.
- Topol, G. A., Reeves, K. D., & Hassanein, K. (2005). Efficacy of dextrose prolotherapy in elite male kicking-sport athletes with chronic groin pain. Archives of Physical Medicine and Rehabilitation, 86(4), 697–702.